Saltar al contenido
Merck

Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma.

Cancer cell (2009-02-03)
Tracy-Ann Read, Marie P Fogarty, Shirley L Markant, Roger E McLendon, Zhengzheng Wei, David W Ellison, Phillip G Febbo, Robert J Wechsler-Reya
RESUMEN

The growth of many cancers depends on self-renewing cells called cancer stem cells or tumor-propagating cells (TPCs). In human brain tumors, cells expressing the stem cell marker CD133 have been implicated as TPCs. Here we show that tumors from a model of medulloblastoma, the Patched mutant mouse, are propagated not by CD133(+) cells but by cells expressing the progenitor markers Math1 and CD15/SSEA-1. These cells have a distinct expression profile that suggests increased proliferative capacity and decreased tendency to undergo apoptosis and differentiation. CD15 is also found in a subset of human medulloblastomas, and tumors expressing genes similar to those found in murine CD15(+) cells have a poorer prognosis. Thus, CD15 may represent an important marker for TPCs in medulloblastoma.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anticuerpo anti-ácido polisiálico-NCAM, clon 2-2B, ascites fluid, clone 2-2B, Chemicon®
Sigma-Aldrich
Anti-Diasialoganglioside GD3 Antibody, clone R24, clone R24, from mouse
Sigma-Aldrich
Anticuerpo anti-A2B5, clon A2B5-105, clone A2B5-105, Chemicon®, from mouse
Sigma-Aldrich
Anti-CD133 Antibody, clone 13A4, clone 13A4, Chemicon®, from rat